These chemicals then make it even harder to sleep well
doi: 10.3389/fnmol.2025.1549366 Received 21 December 2024 Accepted 12 March 2025 Published 07 April 2025 Volume 18 - 2025 Edited by Inigo Ruiz de Azua, Johannes Gutenberg University Mainz, Germany Reviewed by Beatrice Ferrari, San Matteo Hospital Foundation (IRCCS), Italy Ken-ichiro Nakajima, Nagoya University, Japan Keisuke Ito, University of Shizuoka, Japan Updates Copyright 2025 Shiimura, Kojima and Sato
PO, orally
HFpEF is notoriously difficult to treat, and currently, only two drugs, the SGLT2 inhibitors dapagliflozin and empagliflozin, are FDA-approved to treat it
Brain Research Molecular Brain Research 30, 37-47CrossRefGoogle ScholarPubMed 48Kitamura, Y., Furukawa, M., Matsuoka, Y